Symposium on GMP of Pharmaceutical, Herbal, Cosmetic, and Nutraceutical Products

The School of Pharmacy, Monash University Malaysia, successfully hosted the Symposium on GMP of Pharmaceutical, Herbal, Cosmetic, and Nutraceutical Products: Inspection, Licensing, and Compliance on 20 November 2024. The event brought together industry experts, regulatory professionals, and academicians to discuss key trends and challenges in Good Manufacturing Practice (GMP) compliance across various healthcare sectors.

The symposium offered a comprehensive exploration of the pharmaceutical, cosmetic, herbal, and nutraceutical industries' regulatory and business frameworks. It addressed essential topics such as GMP compliance, intellectual property, and market challenges. Esteemed speakers from industry-leading organizations shared their expertise, providing practical insights and fostering constructive discussions.

The symposium featured a diverse range of sessions delivered by distinguished speakers, covering critical aspects of GMP and healthcare product regulation. Mr. Lim Shi Hao, Manager at AstraZeneca, opened with a presentation on the growth potential of the Malaysian pharmaceutical industry, emphasizing strategies to navigate market complexities and leverage emerging opportunities. Mr. Muhammad Mawardi Zakaria, Senior Principal Assistant Director at NPRA, provided detailed insights into the GMP requirements for cosmetic products, traditional medicines, and health supplements, focusing on maintaining quality standards and ensuring safety and efficacy. Furthering the discussion on pharmaceuticals, Mdm. Lee Xiao Ying, also from NPRA, highlighted the importance of rigorous manufacturing practices in ensuring the safety and effectiveness of pharmaceutical products. A lunch talk by Mr. Joganathan, General Manager at AHS Laboratory Supplies, showcased innovative digital solutions for quality control processes, emphasizing advancements in laboratory technology.

The afternoon sessions delved into regulatory and market challenges. Mdm. Sabrina Binti Haron, Chief Compliance Officer at Duopharma, provided guidance on navigating company registration, licensing, and market access in Malaysia, while Mdm. Sharifah Fauziyah Binti Syed Mohthar, COO of Hanan Group of Companies, explored strategies to overcome regulatory hurdles and address market competition. Concluding the sessions, Mdm. Alice Chee Seat Mee, a Regulatory Consultant at PhAMA, delivered an informative talk on intellectual property laws, covering patents, trademarks, and copyright protection, crucial for safeguarding innovations in the healthcare sector. Together, these sessions offered a comprehensive understanding of the evolving landscape of GMP compliance and the healthcare industry in Malaysia.

The symposium highlighted several key takeaways essential for advancing the healthcare industry. The importance of GMP compliance emerged as a cornerstone for ensuring the safety, efficacy, and quality of healthcare products, underscoring the industry's commitment to consumer well-being. Regulatory knowledge, both local and global, was emphasized as critical for fostering compliance and facilitating smooth market entry. Strategic innovation, particularly through the integration of technology and robust intellectual property protections, was highlighted as a driver for industry advancement. Finally, participants gained valuable insights into navigating market challenges, including regulatory compliance and competition, equipping them with practical strategies for sustained success in the healthcare sector.

The symposium underscored the crucial role of GMP and regulatory compliance in the healthcare industry. It inspired stakeholders to innovate and adhere to best practices, ensuring consumer safety and industry growth. The School of Pharmacy at Monash University Malaysia extends gratitude to all participants, speakers, and sponsors for making this event a success.